Related Experiment Video
Updated: May 27, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
New hypotheses for large-scale epigenome alterations in somatic cancer cells: a role for male germ-cell-specific
Sophie Rousseaux1, Saadi Khochbin
1INSERM U823, Université Joseph Fourier, Institut Albert Bonniot, Grenoble, France. khochbin@ujf-grenoble.fr
Abstract:
Oncogenic cell transformation is consistently associated with alterations of the cell epigenome leading to aberrant gene repression and activation. Some of these events, such as the DNA-methylation-based silencing of tumor suppressor genes, are considered to be oncogenic themselves. A much less-studied consequence of these epigenetic misregulations is the abnormal activation of tissue-specific genes in precancerous and transformed cells. Here, we explore the idea that the aberrant expression of germ-cell-specific genes in somatic cancer cells could contribute to malignant cell transformation and cancer progression. Indeed, a significant number of papers have reported the abnormal activation of germ cell-specific genes in various somatic cancers (known as cancer testis [C/T] antigens or factors). Although in most cases the physiological function of these genes remains unknown, functional investigations suggest that they can act as potent genome, epigenome and cellular reorganizers. Hence, in view of the existing literature, we discuss the hypothesis that C/T activation in somatic cells is not only a consequence of global epigenetic deregulation, but also a cause of further large-scale alterations of the epigenome, which themselves have direct oncogenic consequences for the affected cells. Finally, we highlight the fact that C/T factors have the potential to serve as valuable markers for cancer detection, as well as provide promising targets for developing new therapeutical strategies.
Insights
Aberrant activation of germ cell-specific genes (cancer-testis factors) in somatic cancers contributes to malignant transformation. These factors may also drive further epigenetic changes and offer targets for cancer detection and therapy.
Area of Science:
- Epigenetics
- Cancer Biology
- Genomics
Background:
- Epigenetic alterations, including DNA methylation, drive oncogenic cell transformation.
- Aberrant gene activation is a less-studied consequence of epigenetic misregulation in cancer.
- Tissue-specific genes are abnormally activated in precancerous and transformed somatic cells.
Purpose of the Study:
- To explore the hypothesis that aberrant expression of germ cell-specific genes contributes to malignant transformation and cancer progression.
- To investigate the role of cancer-testis (C/T) factors in somatic cancers.
- To discuss C/T factors as both a consequence and cause of epigenetic deregulation in cancer.
Main Methods:
- Literature review and hypothesis discussion.
- Analysis of existing research on C/T antigens in various somatic cancers.
- Exploration of functional investigations into C/T gene roles.
Main Results:
- A significant number of germ cell-specific genes (C/T factors) are abnormally activated in somatic cancers.
- Functional studies suggest C/T factors can reorganize genome, epigenome, and cells.
- C/T factor activation is linked to global epigenetic deregulation and has oncogenic consequences.
Conclusions:
- C/T factor activation in somatic cells is a consequence of epigenetic deregulation.
- C/T factor activation can further alter the epigenome, promoting oncogenesis.
- C/T factors show potential as biomarkers for cancer detection and therapeutic targets.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Inheritance of Chromatin Structures
The Y Chromosome Determines Maleness
Evolution
Around 300 million years ago, the two sex chromosomes diverged from two identical autosomal chromosomes. Over time, the Y chromosome has lost most of its genes, shrinking in size. Today,...
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell

